权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Linking TBI secondary injuries to FTLD- and ALS-like neurodegeneration

TBI 继发性损伤与 FTLD 和 ALS 样神经变性的联系

基本信息

批准号：
10309060
负责人：
ROBERT P BOWSER
金额：
$ 15.7万
依托单位：
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-08-15 至 2024-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10309060
关键词：
Address Alternative Splicing Amyotrophic Lateral Sclerosis Animal Model Animals Appearance Area Biological Markers Brain Injuries Brain Stem Catalogs Cell Nucleus Cervical spinal cord structure Cessation of life Chronic Contralateral Control Animal Cytoplasm Data Development Early Intervention Emergency Situation Emergency department visit Feasibility Studies Frontotemporal Dementia Future Genetic Predisposition to Disease Genetic Transcription Goals Head Hospitalization Human Injury Investigation Ipsilateral Knowledge Lead Life Link Measures Messenger RNA Methodology Military Personnel Mission Molecular Motor Motor Cortex Motor Neuron Disease Motor Neurons Nerve Degeneration Nervous System Trauma Neurobiology Neurodegenerative Disorders Neurons Pathologic Pathology Phenotype Planning Techniques Preventive therapy Process Prosencephalon Protein translocation Public Health Reporting Research Risk Spinal Cord Spinal cord grey matter structure Spliced Genes Sports Supportive care Therapeutic Therapeutic Intervention Tissues Transcript Traumatic Brain Injury Ubiquitination United States United States National Institutes of Health Variant cell injury clinically relevant cognitive disability controlled cortical impact design differential expression frontal lobe frontotemporal lobar dementia-amyotrophic lateral sclerosis functional disability hindbrain injured motor disorder mouse model nervous system disorder novel novel therapeutics pre-clinical protein TDP-43 protein aggregation standard care symptom treatment targeted treatment therapeutic development therapy design transcriptome sequencing transcriptomics wound

项目摘要

Project Summary/Abstract Traumatic brain injury (TBI) initiates primary and secondary damage that may lead to a significantly increased risk for the development of neurodegenerative disorders such as frontotemporal lobar dementia (FTLD) and motor neuron diseases like amyotrophic lateral sclerosis (ALS). Currently there are no standard treatments or cures for TBIs or associated neurodegenerative disorders other than symptomatic treatment and supportive therapies. The goal of this project is to assess and catalogue the extent of FTLD- and ALS-like neurodegenerative effects on cortical neurons, hindbrain motor and premotor neurons, and spinal cord motor neurons following a TBI. The overall objective of this project is twofold: first, to provide a thorough analysis of the FTLD- and ALS- like long-term neurodegenerative effects that will help to alleviate a knowledge gap with specific cellular information concerning the neurodegenerative pathologies following a TBI; and secondly, as the basis of a feasibility study for a much broader investigation into treatment therapies designed to minimize the inherent risk of developing TBI-related neurodegenerative disease later in life. The specific aims of this study are designed to determine the neurodegenerative effects of secondary injuries in an animal model of TBI. These effects include the changes in cellular phenotypes and functions as measured through data derived from immunohistochemical (IHC) and RNA-seq analysis. IHC analysis will focus on known and clinically relevant specific markers of FTLD- and ALS-like neurodegeneration including protein translocations and aggregations in the targeted areas (frontal cortex, hindbrain, cervical spinal cord). RNA-seq analysis will be performed on ipsi- and contralateral areas of the frontal cortex and cervical spinal cord. Analysis will be performed to detect differentially expressed genes and alternative spliced transcripts between injured and uninjured hemispheres of a TBI animal model to tissue collected from uninjured control animals. The data and knowledge obtained from these specific aims will be used to design preventative therapies to alleviate the risk of developing future neurodegenerative disease following TBI.

项目总结/文摘